Tokyo

London

New York

Register

Sign In

EUR/USD

1.0782

-0.0009

-0.09%

GBP/USD

1.2520

0.0045

0.36%

USD/JPY

110.99

-0.3835

-0.34%

USD/CHF

0.9932

0.0010

0.10%

EUR/GBP

0.8612

-0.0039

-0.45%

USD/CAD

1.3354

0.0021

0.16%

NZD/USD

0.7032

-0.0007

-0.11%

EUR/JPY

119.67

-0.5160

-0.43%

EUR/CHF

1.0708

0.0002

0.02%

Aevi Genomic Medicine

NASDAQ: GNMX / / -
1.62-0.08-4.71%Vol 1 219 2811Y Perf -62.56%
Mar 23rd, 2017 16:00
BID1.60 ASK1.69
Open1.73 Previous Close1.70
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
— — 0.00
Potencial %
640.74 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
—    -
Market Cap (mil)63 
Earnings Rating
Price Range Ratio 52wk %
2.23 
Earnings Date

Today's Price Range

1.571.74

 

52wk Range

1.506.89

Summary:

Neutral

Technical Indicators: Strong Buy
Moving Averages: Sell
Performance
1 Month
14.82%
3 Months
5.36%
6 Months
7.63%
1 Year
-62.56%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
GNMX1.62-0.0800-4.71
AAPL140.92-0.5000-0.35
GOOG817.58-12.0100-1.45
MSFT64.87-0.1600-0.25
XOM81.860.10000.12
WFC55.25-0.0800-0.14
JNJ125.90-0.3600-0.29
FB139.53-0.0600-0.04
GE29.620.09000.30
JPM87.39-0.1400-0.16
...

TickerPriceChg.%52 Week High
PVH98.558.48115.40
TRIP42.522.7171.69
COG22.852.7026.74
NKE55.372.6962.64
AAL41.412.6350.64
SWN7.542.4515.59
HBAN13.021.8814.74
CHK5.091.808.20
KORS37.231.7858.63
SLG107.561.75120.63
DD80.561.7481.86
WDC76.191.6881.67
DOW63.831.6664.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.10
Current Ratio 7.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -1 674.50
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.77
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -6.10
Cash Flow Per Share -0.93
Price to Tangible Book5.77
Book Value per Share0.94
Enterprise Value (in ths.)162 040
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-109.33
ROE last 12 Months -98.22
Return on Assets (5Y Avg) -55.05
ROA last 12 Months -88.39
Return on Capital (5Y Avg) -194.61
ROC last 12 Months -98.24
Return on invested Capital Q -21.80
Return on invested Capital Y-21.80
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %0.00
Volume Overview
Volume1 219 281
Shares Outstanding (in ths.)37 110
Trades Count3 754
Dollar Volume1 805 654
Avg. Volume664 564
Avg. Weekly Volume4 180 297
Avg. Monthly Volume1 485 214
Avg. Quarterly Volume627 345

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

Plus500
x